Ipi/Nivo Immunotherpay Approved by NICE

A year on from its first committee meeting to consider this, NICE has finally approved immunotherapy combining Nivolumab and Ipilimumab for the first line treatment of mesothelioma by the NHS. This treatment is commonly known as Ipi/Nivo. NICE is the National Institute for Health and Care Excellence.

What’s the best treatment?

Patients often regard immunotherapy as preferable to chemotherapy. The truth is more complicated. You should take advice from your oncologist about the best treatment for you. However, this decision offers patients and doctors more options to choose from. It has been widely welcomed. It follows a similar decision in Scotland in February 2022.

Find out more here.

Photo by CDC on Unsplash

Posted in